Celgene Corporation

Registered Principal Details

Business Or Interest:
Biopharmaceutical company.

Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.

CEO Name:
Col Barer
Vice President

Contact
AMF
Anne Marie Finley
86 Morris Ave
Summit, NJ 07901
(908) 337-4682
www.celgene.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Greg Chesmore Exclusive Duties N/A Authorized On 1/27/2009 Withdrawn On N/A
Kelly McDowell Exclusive Duties N/A Authorized On 10/1/2010 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 56
Assembly Bill 56
Relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 272
Assembly Bill 272
Relating to: donating drugs and dispensing donated drugs.

Bill Text and History

For
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Celgene supports the language in AB 272 which prohibits donation and redistribution prescription drugs subject to FDA-mandated restricted distribution programs.
Assembly Bill 947
Assembly Bill 947
Relating to: requiring certain identification in order to vote at a polling place or obtain an absentee ballot, verification of the addresses of electors, absentee voting procedure in certain residential care apartment complexes and adult family homes, ide...

Bill Text and History

For
Notification Date
4/23/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Requiring parity in health coverage (patient out of pocket expenses) for oral and IV/infused oncology therapies.
Assembly Bill 974
Assembly Bill 974
Relating to: insurance coverage of oral and injected chemotherapy.

Bill Text and History

For
Notification Date
6/9/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Parity in health insurance coverage of oral chemotherapy products
Senate Bill 198
Senate Bill 198
Relating to: donating drugs and dispensing donated drugs.

Bill Text and History

For
Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Development, drafting or introduction of a proposal relating to
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.

Action Intended To Affect
Legislative Matter

Notification Date
2/4/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Bills to revamp Wisconsin's cancer and chronic disease drug repository program.
Development, drafting or introduction of a proposal relating to
Bills to revamp Wisconsin's cancer and chronic disease drug repository program.

Action Intended To Affect
Legislative Matter

Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Draft resolution regarding placenta blood/cord blood banking and research.
Development, drafting or introduction of a proposal relating to
Draft resolution regarding placenta blood/cord blood banking and research.

Action Intended To Affect
Legislative Matter

Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Development, drafting or introduction of a proposal relating to
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.

Action Intended To Affect
Legislative Matter

Notification Date
11/10/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Development, drafting or introduction of a proposal relating to
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.

Action Intended To Affect
Rule (by a state agency)

Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
Development, drafting or introduction of a proposal relating to
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.

Action Intended To Affect
Legislative Matter

Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
Total Lobbying Expenditures 2009
January - June
$8,706.21
2009
July - December
$1,421.87
2010
January - June
$5,761.06
2010
July - December
$7,516.27
Total $23,405.41
Total Hours Communicating 2009
January - June
23.75
2009
July - December
6.00
2010
January - June
15.00
2010
July - December
14.00
Total 58.75
Total Hours Other 2009
January - June
33.50
2009
July - December
5.00
2010
January - June
25.00
2010
July - December
54.00
Total 117.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: advertising for prescription drugs.
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
5%
2009
July - December
2010
January - June
2010
July - December
Total 2%
Relating to: donating drugs and dispensing donated drugs.
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
50%
2009
July - December
50%
2010
January - June
2010
July - December
Total 20%
Relating to: donating drugs and dispensing donated drugs.
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
50%
2010
January - June
20%
2010
July - December
Total 8%
Relating to: insurance coverage of oral and injected chemotherapy.
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
2010
January - June
65%
2010
July - December
50%
Total 34%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
15%
2009
July - December
2010
January - June
10%
2010
July - December
Total 7%
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
30%
2009
July - December
2010
January - June
2010
July - December
Total 10%
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
2010
January - June
5%
2010
July - December
Total 1%
2009
January - June
2009
July - December
2010
January - June
2010
July - December
Total
2009
January - June
2009
July - December
2010
January - June
2010
July - December
50%
Total 19%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures